Krystal Biotech Inc. Logo

Krystal Biotech Inc. (4KB)

XSTU

Currency in EUR
291.90
-5.20 (-1.75%)

Real-time Data

06:00 AM

Day's Range

288.20
296.80

52 wk Range

116.55
334.10

Overview - 4KB - Krystal Biotech Inc.

Key Statistics

Valuation

Enterprise Value

6.68B

P/E (Trailing)

‪42.50‬

PEG Ratio

‪1.08‬

Price / Sales (TTM)

‪19.50‬

Price / Book

‪7.38‬

EV / EBITDA

‪39.16‬

Profitability

Gross Margin

‪94.60%‬

Profit Margin

‪54.81%‬

Operating Margin

‪48.99%‬

Return on Assets

‪9.36%‬

Return on Equity

‪20.12%‬

Ownership

Shares Outstanding

29.59M

Float

23.56M

Held by Insiders

‪10.82%‬

Held by Institutions

‪102.52%‬

Price stats

Beta

‪0.53‬

50-Day Avg

‪301.82‬

200-Day Avg

‪245.00‬

Dividends

Payout Ratio

‪0.00%‬

Market Cap - 4KB - Krystal Biotech Inc.

Peers - 4KB - Krystal Biotech Inc.

Peer Comparison

Compared with companies in Biotechnology listed on XSTU.

Profile Summary - 4KB - Krystal Biotech Inc.

About

Krystal Biotech Inc. is a biotechnology company primarily focused on developing and commercializing gene therapy products for patients with rare dermatological conditions. Its innovative platform harnesses gene delivery technology to address unmet medical needs by developing a pipeline of products aimed at treating…

SectorHealthcare
IndustryBiotechnology
Employees295
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.